Archived Press Releases |
| Date |
Title (click to view the full text) |
| 17-Dec-2009 |
Unigene Announces Promising Preclinical Results in Its Obesity
Peptide Program |
| 10-Dec-2009 |
Independent Advisory Committee Recommends Continuation of Phase III
Oral Calcitonin Studies for Osteoporosis and Osteoarthritis |
| 9-Dec-2009 |
Unigene Announces Significant Cost Savings and Corporate Restructuring |
| 9-Nov-2009 |
Unigene Announces Financial Results for Third Quarter 2009 |
| 4-Nov-2009 |
Unigene to Release Third Quarter 2009 Results and Host Conference Call |
| 20-Oct-2009 |
Unigene to Host Conference Call to Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics |
| 20-Oct-2009 |
Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics |
| 2-Sep-2009 |
U.S. District Court Confirms Validity of Unigene's Fortical(R) Patent |
| 10-Aug-2009 |
Unigene Announces Financial Results For Second Quarter 2009 |
| 4-Aug-2009 |
Unigene to Release Second Quarter 2009 Results and Host Conference Call |
| 29-May-2009 |
Unigene's First Site-Directed Bone Growth Patent Issues |
| 29-May-2009 |
Unigene Draws Down Remaining $5 Million from Non-Convertible Debt Financing |
| 14-May-2009 |
Hot Flashes May Prompt Closer Look at Bone Health |
| 11-May-2009 |
Unigene Reports Financial Results For First Quarter 2009 |
| 5-May-2009 |
Unigene to Release First Quarter 2009 Results and Host Conference Call |
| 26-Mar-2009 |
Pedaling Toward Osteoporosis? |
| 16-Mar-2009 |
Unigene Reports Financial Results for Fourth Quarter And Year-End 2008 |
| 16-Mar-2009 |
Unigene Reports Positive PTH Clinical Study Results |
| 12-Mar-2009 |
Webcast Alert: Fourth Quarter 2008 Earnings Conference Call |
| 9-Mar-2009 |
Unigene to Release Year-End Results and Host Conference Call |
| 2-Feb-2009 |
Unigene Clinical Study Suggests Novel Treatment Regimen for Osteoporosis |
| 20-Jan-2009 |
Unigene Reports Positive Results on a Novel Peptide for Reducing Food Consumption |
| 7-Jan-2009 |
Unigene Laboratories, Inc. Announces Addition of Independent Director to Company Board |
| 8-Dec-2008 |
Unigene Announces Preliminary Injunction Entered in Patent Infringement Lawsuit |
| 14-Nov-2008 |
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty |
| 13-Nov-2008 |
Osteoporosis Drugs May Prevent Future Bone Growth |
| 13-Nov-2008 |
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: EVOL, MRGE, BTN, ITRO, UGNE, FNIX, NVSR, UDSG, HRAL, BNPD |
| 13-Nov-2008 |
FEATURE/Osteoporosis Drugs May Prevent Future Bone Growth |
| 10-Nov-2008 |
Unigene Announces Financial Results For Third Quarter 2008 |
| 5-Nov-2008 |
Unigene to Release Third Quarter Financial Results and Host Conference Call |
| 6-Oct-2008 |
Unigene Initiates Phase I Clinical Study for Oral PTH |
| 30-Sep-2008 |
Unigene Enters into Agreement for $20 Million Non-Convertible Debt Financing |
| 18-Sep-2008 |
Unigene Reports on Design of Clinical Program for Oral Calcitonin |
| 11-Aug-2008 |
Unigene Announces Financial Results For Second Quarter 2008 |
| 11-Aug-2008 |
FEATURE/Olympian Bone Health for China |
| 11-Aug-2008 |
Olympian Bone Health for China |
| 6-Aug-2008 |
Unigene to Release Second Quarter Financial Results and Host Conference Call |
| 10-Jul-2008 |
Unigene CEO Discusses Value of Peptides and Company's Technologies in Two Leading Pharmaceutical Trade Publications |
| 12-May-2008 |
Unigene Announces Financial Results For First Quarter 2008 |
| 12-May-2008 |
China Joint Venture Partner to Invest $2 Million in Unigene |
| 8-May-2008 |
Unigene to Release First Quarter 2008 Results and Host Conference Call |
| 29-Apr-2008 |
FDA Approves Second Improvement to Unigene's Calcitonin Manufacturing Process |
| 23-Apr-2008 |
Unigene Joint Venture Breaks Ground for Global Biotechnology Park in China |
| 17-Mar-2008 |
Unigene Announces Financial Results for Fourth Quarter and Year-End 2007 |
| 13-Mar-2008 |
Unigene Restates Policy on Analyst Reports |
| 12-Mar-2008 |
Unigene Reports Transfer of Beneficial Ownership of Shares by Management |
| 12-Mar-2008 |
Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin |
| 11-Mar-2008 |
Unigene to Release Year End Results and Host Conference Call on March 18, 2008 |
| 10-Mar-2008 |
FEATURE/Boning up on New Osteoporosis Risk Guidelines |
| 10-Mar-2008 |
Boning up on New Osteoporosis Risk Guidelines |
| 13-Feb-2008 |
Unigene to Present at the 20th Annual Roth Capital Partners Growth Stock Conference |
| 12-Feb-2008 |
Unigene Announces Publication of Initial Results of Site-Directed Bone Growth Studies |
| 11-Feb-2008 |
Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin |
| 17-Jan-2008 |
FDA Approves Improvement to Unigene's Calcitonin Manufacturing Process |
| 8-Jan-2008 |
Unigene and Shijiazhuang Pharmaceutical Group to Expand Chinese Joint Venture |
| 19-Dec-2007 |
Unigene States That New Government Study Reports That Many Osteoporosis Medications Prevent Fractures, but None is Proven Best |
| 12-Nov-2007 |
Unigene Announces Financial Results for the Third Quarter of 2007 |
| 7-Nov-2007 |
Unigene to Release Third Quarter Results and Host Conference Call on November 12th |
| 1-Nov-2007 |
Unigene to Present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference |
| 25-Oct-2007 |
Unigene Reports Successful Completion of Oral Calcitonin Human Study |
| 20-Sep-2007 |
Unigene and Yale Present Longer-Term Animal Data for Novel Site-Directed Bone Growth Technology |
| 18-Sep-2007 |
Unigene to Present at the UBS Global Life Sciences Conference |
| 29-Aug-2007 |
Unigene to Present at the ROTH 2007 New York Conference |
| 10-Aug-2007 |
Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease from University of London |
| 10-Aug-2007 |
Unigene Announces Financial Results for the Second Quarter of 2007 |
| 7-Aug-2007 |
Unigene to Release Second Quarter Results and Host Conference Call on August 10th |
| 3-Aug-2007 |
Unigene to Present at Canaccord Adams' 27th Global Growth Conference |
| 2-Aug-2007 |
Unigene Initiates Oral Calcitonin Clinical Study in Humans |
| 27-Jun-2007 |
Unigene and Yale Present Novel Site-Directed Bone Growth Technology for Strengthening Bones |
| 18-Jun-2007 |
Unigene to Present Initial Animal Data on Site-Directed Bone Growth |
| 5-Jun-2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated |
| 11-May-2007 |
Unigene Announces Strong Increase in Revenue and Improved Quarterly Income for First Quarter 2007 |
| 11-May-2007 |
Unigene Restructures Debt |
| 8-May-2007 |
Unigene to Release First Quarter 2007 Results and Host Conference Call on May 11th |
| 7-May-2007 |
CORRECTING and REPLACING Unigene to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference on May 8, 2007 |
| 20-Mar-2007 |
Unigene's Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis |
| 19-Mar-2007 |
Unigene Announces Financial Results for Fourth Quarter and Year-End 2006 |
| 13-Mar-2007 |
Unigene to Release Fourth Quarter and Year-End 2006 Results and Host Conference Call on March 19th |
| 27-Feb-2007 |
Unigene Achieves $5.5 Million Milestone in Calcitonin Collaboration for Phase III Initiation |
| 15-Feb-2007 |
Unigene Receives Phase II SBIR Grant for Novel Peptide Discovery Program |
| 29-Jan-2007 |
Unigene Enters Supply Agreement to Manufacture Osteoporosis Peptide |
| 30-Nov-2006 |
Unigene Engages University Clinicians to Advise on Bone Growth Program |
| 9-Nov-2006 |
Unigene Announces Results for the Third Quarter of 2006 |
| 8-Nov-2006 |
Unigene to Release Third Quarter 2006 Results and Host Conference Call on November 10th |
| 3-Nov-2006 |
Unigene to Present at the 8th Annual Rodman and Renshaw Healthcare Conference on November 8th 2006 |
| 19-Sep-2006 |
Unigene to Present at the UBS Global Life Sciences Conference on September 27, 2006 |
| 30-Aug-2006 |
Unigene to Present at the ThinkEquity Partners Conference; Fortical(R) Sales to Upsher-Smith Resume |
| 11-Aug-2006 |
Unigene Named Ninth Fastest Growing Technology Company in New Jersey in Deloitte's Technology Fast 50 Program |
| 10-Aug-2006 |
Unigene Announces Results for the Second Quarter of 2006 |
| 8-Aug-2006 |
Unigene to Release Second Quarter 2006 Results and Host Conference Call |
| 25-Jul-2006 |
Unigene and Upsher-Smith File Patent Infringement Lawsuit against Canadian Drug Manufacturer |
| 11-May-2006 |
Unigene Announces Results for the First Quarter of 2006 |
| 10-May-2006 |
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel |
| 9-May-2006 |
Unigene to Release First Quarter 2006 Results and Host Conference Call |
| 31-Mar-2006 |
Unigene Begins Media Education Initiative to Promote Bone Health; CEO Interviewed by Television Stations Nationwide about Osteoporosis |
| 17-Mar-2006 |
Unigene Announces Results for 2005 |
| 17-Mar-2006 |
Unigene Enters into Agreement to Sell $13 Million in Equity Securities |
| 14-Mar-2006 |
Unigene to Release Year-End Results and Host Conference Call |
| 15-Feb-2006 |
Unigene Elects Peter Slusser and Bruce Morra, Senior Financial and Pharmaceutical Executives, to Board of Directors |
